๐ฐ Thomas Equels News
Page 2 - Thomas Equels News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thomas Equels. Real-time updates on events, politics, business and more.
July 28, 2022
AIM ImmunoTech Inc (NYSE:AIM) has announced what it calls positive preliminary pilot study data from its ongoing Expanded Access Program (EAP) evaluating...
June 22, 2022
Virtual Investor Conferences (VIC), the leading proprietary investor conference series, in partnership with Zacks Small-Cap Research, today announced the...
June 21, 2022
AIM ImmunoTech Inc (NYSE:AIM) announced that it has entered into a lease agreement with the New Jersey Economic Development Authority for a 5,210 square...
June 21, 2022
Virtual Investor Conferences (VIC), the leading proprietary investor conference series, in partnership with Zacks Small-Cap Research, today announced the...
April 21, 2022
Ampligen has demonstrated in pre-clinical and now human clinical studies a potential to enhance efficacy of PD-1 and/or PD-L1 checkpoint inhibitors ...
April 21, 2022
Ampligen has demonstrated in pre-clinical and now human clinical studies a potential to enhance efficacy of PD-1 and/or PD-L1 checkpoint inhibitors Ampligen's anti-tumor potential is demonstrated with
April 21, 2022
21.04.2022 - Ampligen has demonstrated in pre-clinical and now human clinical studies a potential to enhance efficacy of PD-1 and/or PD-L1 checkpoint inhibitors Ampligenโs anti-tumor potential is demonstrated with checkpoint blockade therapies in human clinical ... Seite 1
April 13, 2022
Australis Capital Inc (CSE:AUSA, OTCQB:AUSAF), the cannabis company doing business as Audacious, gave shareholders an update on its commercial operations in...
April 12, 2022
Australis Capital Inc (CSE:AUSA, OTCQB:AUSAF), the cannabis company doing business as Audacious, gave shareholders an update on its commercial operations in...
April 12, 2022
AIM ImmunoTech Inc. , an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19,... | April 12, 2022